KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Land & Improvements (2016 - 2022)

Historic Land & Improvements for Amgen (AMGN) over the last 14 years, with Q4 2022 value amounting to $292.0 million.

  • Amgen's Land & Improvements rose 465.95% to $292.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $292.0 million, marking a year-over-year increase of 465.95%. This contributed to the annual value of $292.0 million for FY2022, which is 465.95% up from last year.
  • Latest data reveals that Amgen reported Land & Improvements of $292.0 million as of Q4 2022, which was up 465.95% from $279.0 million recorded in Q4 2021.
  • Over the past 5 years, Amgen's Land & Improvements peaked at $292.0 million during Q4 2022, and registered a low of $259.0 million during Q4 2020.
  • In the last 5 years, Amgen's Land & Improvements had a median value of $265.0 million in 2018 and averaged $271.6 million.
  • Per our database at Business Quant, Amgen's Land & Improvements tumbled by 636.04% in 2018 and then skyrocketed by 772.2% in 2021.
  • Over the past 5 years, Amgen's Land & Improvements (Quarter) stood at $265.0 million in 2018, then dropped by 0.75% to $263.0 million in 2019, then fell by 1.52% to $259.0 million in 2020, then increased by 7.72% to $279.0 million in 2021, then grew by 4.66% to $292.0 million in 2022.
  • Its Land & Improvements stands at $292.0 million for Q4 2022, versus $279.0 million for Q4 2021 and $259.0 million for Q4 2020.